Home arrow Publication Series arrow Analytical Tool arrow Triple Analysis
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Browse

Order by:     Display #  
Target Atlas of Apoptopic Drugs & Focus on Lung Cancer & Melanom
This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&D overview of lung cancer and melanoma.

$5 080.00    Product Details...

Big Pharmas R&D Strategy in Oncology & Lung Cancer and Melanoma
This is the report for professionals interested to grasp big pharma’s R&D strategy in oncology and at the same time have an extensive R&D overview of the lung cancer and melanoma field.

$5 080.00    Product Details...

Antibody Drug Targets and Special Focus on Leukemias & Lymphomas
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Leukemias and Lymphomas, which are all subjects to an extensive number of innovative drug candidates.

$5 050.00    Product Details...

Target Atlas of Apoptopic Drugs and Focus on Breast & Prostate
This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&D overview of breast- and prostate cancer.

$5 080.00    Product Details...

Big Pharmas R&D Strategy In Oncology & Breast & Prostate Cancer
This is the report for professionals interested to grasp big pharma’s R&D strategy in oncology and at the same time have an extensive R&D overview of the breast- and prostate cancer field.

$5 080.00    Product Details...

Antibody Drug Target and Special Focus on Melanoma and NSCLC
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Melanoma, and NSCLC, which are all subjects to an extensive number of innovative drug candidates.

$5 080.00    Product Details...

Triple Analysis: Apoptosis, PKI & Anti-Angiogenesis in Oncology
This extensive 345+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the three key oncology areas: Apoptotic agents, Protein Kinase Inhibitors and Anti-Angiogenic agents.

$4 790.00    Product Details...

Antibody Drug Targets and Focus on Breast- & Prostate Cancer
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Breast- and Prostate Cancer, which are all subjects to an extensive number of innovative drug candidates.

$5 050.00    Product Details...

Big Pharmas R&D Strategy In Oncology & Leukemias & Lymphomas
This is the report for professionals interested to grasp big pharma’s R&D strategy in oncology and at the same time have an extensive R&D overview of the leukemia and lymphoma field.

$5 080.00    Product Details...

Triple Analysis: Melanoma, Colorectal & Lung Cancer
In this 400 page report BioSeeker Group has compiled and analyzed information concerning drug development and competitive situation on three major cancer indications.

$4 332.00    Product Details...

Triple Analysis: Lymphoma, PK Inhibitors & Antibodies
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Lymphoma, Protein Kinase Inhibitors and Therapeutic Antibodies, which are all subjects to an extensive number of innovative drug candidates. T

$4 367.00    Product Details...

Triple Analysis:Kinase Inhibitors, Antibodies&Vaccines in Cancer
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Protein Kinase Inhibitors (PKI), Antibodies and Vaccines in Oncology, which are all subjects to an extensive number of innovative drug can

$4 367.00    Product Details...

Triple Analysis: Melanoma, Antibodies and Vaccines in Oncology
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Melanoma Therapeutics, Antibodies and Vaccines in Oncology, which are all subjects to an extensive number of innovative drug candidates. This

$4 367.00    Product Details...

Triple Analysis: NSCLC, PK Inhibitors & Anti-Angiogenic Agents
p>In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Non Small Cell Lung Cancer Therapeutics, Protein Kinase Inhibitors and Anti-angiogenesis and Vascular Targeting in Oncology, which are all s

$4 367.00    Product Details...

Triple Analysis: Apoptosis Agents, Antibodies and Vaccines
This extensive 350+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the three mentioned key oncology areas.

$4 367.00    Product Details...




Display #  
Results 1 - 15 of 15

Latest News

Expert Views: Are the US and emerging markets ready for the generic drug boom?
Read more...
 
Expert Views: Cytotoxic therapies to feel sting of generics
Read more...
 
Expert Views: Hope for Obama's healthcare IT plan
Read more...
 

Latest Products


Currently Druggable in Colorectal Cancer
Global Medical Tourism

Stakeholder Opinions: Diabetic Renal Disease
Pipeline Insight: Orphan Diseases Myasthenia Gravis

Financial Deals Industry Tracker: Pharma & Healthcare Sep-2008
Sales Force Effectiveness

Forecast Model: Antidyslipidemics
Financial Deals Industry Tracker: Pharma & Healthcare Aug 2008

Stakeholder Insight: Osteoporosis
Pipeline and Commercial Insight: Schizophrenia

Emerging Markets Series: The Pharma Market of South Korea
Merck KGaA: PharmaVitae Profile

Les Laboratoires Servier: PharmaVitae Profile 2008
Solvay S.A.: PharmaVitae Profile 2008

Biogen Idec Inc.: PharmaVitae Profile 2008
Strategic Perspectives: Antidyslipidemics Current market...

M&A trends in Pharma
Commercial Insight: Pain Market Overview

Sepracor Inc.: PharmaVitae Profile 2008
RNA therapy: the next big thing after monoclonal antibodies?

© BioMarket Group
BioSeeker Group and BioMarket Group are both trademarks of BioSeeker Group AB